glp-1 drugs and pregnancy Receptor Agonists, Fertility Restoration, Reproductive Safety in Women of Reproductive Age: A Narrative Review AJOG Expert Review: Glucagon-like peptide-1

Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway

This difference was statistically significant ( p =0.037)

Beyond obesity and type 2 diabetes, the therapeutic potential of GLP-1 RAs extends to a range of conditions such as cardiovascular disease, liver disease, neurodegenerative disease, and substance abuse disorders

Obesity is a chronic condition like high blood pressure, elevated cholesterol or high blood sugar and requires chronic treatment, said lead author Dr

Additionally, the importance of optimized delivery strategies to ensure sustained and controlled release of GLP-1 analogs is discussed

Group design and comparative analysis Comparative safety profile: GLP-1 receptor agonist monotherapy versus combination therapy with metformin The pharmacovigilance analysis encompassed 262,355 adverse event (AE) reports associated with GLP-1 receptor agonist therapy